Company Filing History:
Years Active: 2017-2023
Title: Todd Langevin: Innovator in Brain Stimulation Technology
Introduction
Todd Langevin is a notable inventor based in Edina, MN (US). He has made significant contributions to the field of neuromodulation, particularly in the development of brain stimulation systems. With a total of 3 patents to his name, Langevin is recognized for his innovative approaches to treating neurological diseases and disorders.
Latest Patents
Langevin's latest patents include a brain stimulation system that features multiple stimulation modes. This system is designed to treat patients by utilizing a stimulator to stimulate brain tissue. It incorporates a controller for setting stimulation parameters and a diagnostic tool for measuring patient parameters and producing diagnostic data. The stimulation parameters consist of both test and treatment stimulation parameters. The stimulator delivers test stimulation energy to the brain tissue based on at least one test stimulation parameter and subsequently delivers treatment stimulation energy based on at least one treatment stimulation parameter. The system is constructed to treat various neurological diseases or disorders, providing methods for effective treatment.
Career Highlights
Throughout his career, Todd Langevin has focused on advancing the field of functional neuromodulation. His work has been instrumental in developing technologies that enhance the quality of life for patients suffering from neurological conditions. His innovative spirit and dedication to research have positioned him as a key figure in this specialized area.
Collaborations
Langevin has collaborated with notable colleagues, including J Christopher Flaherty and Daniel J O'Connell. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in brain stimulation technology.
Conclusion
Todd Langevin's contributions to brain stimulation technology exemplify his commitment to innovation in the medical field. His patents and collaborative efforts continue to pave the way for advancements in treating neurological disorders.